BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SRP-1001 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SRP-1001\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06131983-10768@assetmemo.bio
DTSTAMP:20261121T005659Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:SRP-1001: Phase 1/2 readout est. (NCT06131983)
DESCRIPTION:SRP-1001\, phase 1/2\, Facioscapulohumeral Muscular Dystrophy.\
 nStudy: Study of SRP-1001 in Adult and Adolescent Participants With Facios
 capulohumeral Muscular Dystrophy Type 1\nEstimated primary completion: 31 
 December 2028. This is a ClinicalTrials.gov estimate\, not a confirmed rea
 dout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/srp-10
 01#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0
 6131983
URL:https://assetmemo.bio/drug/srp-1001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
